APA (7th ed.) Citation

HJ, H., SS, P., YS, L., TH, K., DJ, S., JH, K., . . . JT, H. (2026). CHI3L1 monoclonal antibody therapy mitigates cognitive impairment by inhibiting neuroinflammation through ERK and NF-κB pathway in Tg2576 mice. Frontiers in molecular neuroscience, 18, 1728279. https://doi.org/10.3389/fnmol.2025.1728279

Chicago Style (17th ed.) Citation

HJ, Ham, et al. "CHI3L1 Monoclonal Antibody Therapy Mitigates Cognitive Impairment by Inhibiting Neuroinflammation Through ERK and NF-κB Pathway in Tg2576 Mice." Frontiers in Molecular Neuroscience 18 (2026): 1728279. https://doi.org/10.3389/fnmol.2025.1728279.

MLA (9th ed.) Citation

HJ, Ham, et al. "CHI3L1 Monoclonal Antibody Therapy Mitigates Cognitive Impairment by Inhibiting Neuroinflammation Through ERK and NF-κB Pathway in Tg2576 Mice." Frontiers in Molecular Neuroscience, vol. 18, 2026, p. 1728279, https://doi.org/10.3389/fnmol.2025.1728279.